Facebook Twitter LinkedIn Instagram Email Printer Google Plus

John Rudoy

Principal, Oliver Wyman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Women, healthcare's primary consumers, are 20 percent more likely than men are to express frustrations with the healthcare system.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Senior Consultant, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

How pharmaceutical companies can better define, measure, and deliver value to patients.

Principal, Oliver Wyman
Senior Consultant, Health & Life Sciences, Oliver Wyman

Advice on how the healthcare industry can address the pharmaceutical cost problem.

Principal, Oliver Wyman

Adaptability is key for the future healthcare workforce. But those organizations interested in outsourcing their talent need these strategic tools to remain competitive.

Principal, Oliver Wyman

According to Oliver Wyman’s Consumer Survey of US Healthcare, women are more engaged in their health decisions than men. Healthcare companies must give female consumers the kind of health system they're seeking.

Chief Strategy Officer, BCBS of Massachusetts
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Oliver Wyman

Some of our 2017 healthcare predictions on value-based care, consumers, mergers, startups, and pharma came true, while others were less predictable.

Principal, Oliver Wyman

Insights in your inbox

Subscribe